from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2897c/-

LFCtreatmentdescriptionclass of inhibitor

0.025

Amikacinug/mL Amikacintranslation

0.190

Cap5-10ug/mL Capreomycintranslation

-0.164

Rox10-50 ug/mL Roxithromycintranslation

0.785

SM2-5 ug/mL Streptomycintranslation

0.795

Tet5-10 ug/mL Tetracyclinetranslation

0.062

Rif0.2-5ug/mL Rifampicintranscription

-0.138

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.726

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.214

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.227

CPZ10-50 ug/mL Chlorpromazinerespiration

2.220

Clofazimine10-13 ug/mL Clofaziminerespiration

0.608

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.829

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.054

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.296

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.330

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.118

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.356

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.367

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.219

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.556

KCN5-20 ug/mL Potassium cyaniderespiration

-0.598

NaN30.2-2 mM Sodium aziderespiration

-0.448

Nigericin50 uM Nigericinrespiration

0.033

TRC10-150 ug/mL Triclosanrespiration

-0.315

TRZ10-25 ug/mL Thioridazinerespiration

-0.125

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.313

menadione6-10 ug/mL Menadionerespiration

0.316

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.011

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.009

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.365

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.214

NRP_1Non-replicating persistence stage 1dosRassociated

-0.177

Amp0.2mg/mL AmpicillincellWall

0.585

Cephalexin20-100 ug/mL CephalexincellWall

0.098

Cerulenin0.32-5 ug/mL CerulenincellWall

0.136

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.083

EMB10-20 ug/mL EthambutolcellWall

-0.374

Eta12-40 ug/mL EthionamidecellWall

-0.077

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.021

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.525

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.062

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.313

BZA0.12 mg/mL BenzamidearomaticAmides

-0.802

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.478

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.215

H2O24 mM hydrogen peroxideDNAdamaging

0.034

Levo10 ug/mL LevofloxacinDNAdamaging

-0.922

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.582

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.224

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.230

UVUV-irradiationDNAdamaging

0.227

ARP41-4 ug/mL Antitubercular compound ARP4?

0.403

Antimycin12.5-50 ug/mL Antimycin A?

-0.593

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.349

PA_110-50 ug/mL Antitubercular compound PA-1?

0.877

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.197

PA8240.2-2 ug/mL PA-824?

0.144

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.537

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.787

Verapamil50 uM Verapamil?

0.000

mercaptoethanol2 mM 2-Mercaptoethanol?

0.619

methoxatin10-20 ug/mL Methoxatin?